ALA-PDT-treated glioma did not show a significant increase of extracellular CRT and HMGB1,42 whereas, in our unpublished data, we show that Rutherrin-PDT induces a significant increase in extracellular CRT. Here, HMGB1 is linked to central nervous system cancer.